Lokivetmab (Cytopoint) in Dogs
Generic: Lokivetmab
Lokivetmab, commercially known as Cytopoint, is an injectable monoclonal antibody treatment designed to specifically target and neutralize the itch-inducing cytokine Interleukin-31 in dogs with atopic dermatitis.
This medication is intended for dogs.
Overview
Lokivetmab, marketed as Cytopoint (Locivetmab), represents a significant breakthrough in veterinary dermatology as a biological therapeutic rather than a traditional chemical immunosuppressant. It is a caninized monoclonal antibody that provides targeted relief for dogs suffering from the chronic, debilitating effects of allergic dermatitis. By focusing exclusively on the neurological pathways associated with the sensation of pruritus, it allows clinicians to manage skin disease without the broad systemic effects often seen with corticosteroids or older oral antipruritic agents. While effective for itch management, veterinarians often use it alongside topical therapies like Douxo Chlorhexidine to manage secondary infections that frequently accompany allergic skin barrier damage. Clinical data suggests that many patients experience a significant reduction in scratching within 24 hours of administration, which provides immediate behavioral relief for the animal and peace of mind for the owner. When the skin barrier is severely compromised by inflammation, additional treatments such as Hydrocortisone Topical may be required to soothe localized surface irritation while the monoclonal antibody works internally. Furthermore, if the patient develops secondary bacterial pyoderma, clinicians may utilize Mupirocin or other antimicrobial agents in conjunction with the injection to resolve the infection. It is critical to note that while this medication is highly effective for itch, it does not cure the underlying allergy, and long-term multimodal management remains essential for patient comfort. This may include environmental control, dietary modification, or the use of specific anti-fungal treatments like Ketoconazole Topical if the patient suffers from concurrent yeast overgrowth.
What It Treats
- Atopic Dermatitis: The primary use, treating chronic allergic skin disease.
- Environmental Allergies: Relief from pruritus caused by pollen, dust, or mold.
- Acute Pruritus: Rapid cessation of intense scratching behaviors.
- Allergic Dermatitis: Managing generalized inflammation and irritation of the skin.
How It Works
Lokivetmab functions as a specialized monoclonal antibody that binds to canine Interleukin-31 (IL-31). IL-31 is a cytokine—a signaling protein—that is a key mediator of itch in dogs. By sequestering IL-31, the medication prevents it from binding to its receptor on the nerve endings in the skin, effectively blocking the signal that tells the brain the skin is itchy. Unlike traditional steroids, which dampen the entire immune system, this targeted approach leaves the rest of the immune function largely intact, which is a major advantage for safety and long-term use. The biological nature of the drug allows it to be processed and cleared by the body similarly to naturally occurring antibodies, meaning it does not rely on liver or kidney metabolism in the same way traditional oral drugs do.
Dosage
The recommended dosage is 2 mg/kg administered via a subcutaneous injection by a veterinary professional, once every four to eight weeks based on the individual dog's response. Owners should strictly adhere to the dosing interval prescribed by their veterinarian, as the efficacy duration can vary significantly between individual patients based on the severity of their allergy and the environmental allergen load.
Administration
The medication is supplied as a sterile solution for subcutaneous injection. It must be administered exclusively by a veterinarian or trained veterinary technician. Because the product is a protein-based biological, it must be handled carefully, kept refrigerated at all times during storage, and should never be shaken vigorously, as this can denature the protein and render the medication ineffective.
Storage
Lokivetmab must be stored in a refrigerator at temperatures between 2°C and 8°C (36°F to 46°F). It must be kept in the original carton to protect the contents from light and should never be frozen. Once removed from refrigeration, it should be administered promptly to ensure stability.
Contraindications
Lokivetmab is contraindicated in dogs with a known hypersensitivity to the drug itself. Because it is a biological product, there is always a rare potential for an anaphylactic or severe allergic reaction, so animals should be monitored for a short period after the initial injection. It is generally safe for dogs of all ages, including puppies, but its safety has not been specifically studied in breeding, pregnant, or lactating animals; therefore, use in these groups should be evaluated by a veterinarian on a case-by-case basis. It should not be used as a primary treatment for skin infections, parasites like fleas or mites, or other non-allergic skin conditions, as it will not address the root cause of these issues.
Interactions
One of the major benefits of lokivetmab is that it is not processed through the liver’s cytochrome P450 enzyme system, which minimizes the risk of significant drug-drug interactions. It has been safely used in clinical trials in conjunction with other common veterinary medications, including antibiotics, parasiticides, antifungals, and vaccines. Because of its targeted mechanism, it does not typically interfere with the metabolism of other drugs, making it an excellent candidate for patients already on complex medication regimens for chronic conditions.
Side Effects
- Injection site discomfort or swelling
- Lethargy or fatigue following administration
- Gastrointestinal upset such as vomiting or diarrhea
- Hypersensitivity reactions (rare, including facial swelling or hives)
- Dermatological changes including hair loss or crusting (very rare)
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.